VXRT News and Press, Vaxart Inc. From 04/30/20

Vaxart (NASDAQ: VXRT ) is up  15%  premarket on robust volume in reaction to its announcement of positive preclinical data on its oral COVID-19 vaccine candidates, several of which generated immune responses in all tested animals after a single dose. More news on: Vaxart, Inc.,...

Another round of stock market news has triggered momentum for several penny stocks . During a week where the bulls have started to take control, eyes are on earnings. But there are still concerns over the looming coronavirus backlash that may not even be realized yet. The eurozone’s e...

SOUTH SAN FRANCISCO, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has obtained positive pre-clinical results for its COVI...

Shares of Vaxart (NASDAQ: VXRT) , a clinical-stage biotech focused on the development of orally administered vaccines, were down by 10.7% on Tuesday. The market is responding to the company's corporate update, which previewed Vaxart's financial results for the first quarter.  In its cor...

Preparations for the Manufacturing of GMP Vaccine at Emergent BioSolutions Ongoing Vaxart is Participating in Maxim’s Infectious Disease Virtual Conference on May 5, 2020 SOUTH SAN FRANCISCO, Calif., April 28, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechno...

Gainers: Yield10 Bioscience (NASDAQ: YTEN ) +68% . More news on: Yield10 Bioscience, Inc., Aytu BioScience, Inc., Avadel Pharmaceuticals plc, Stocks on the move, , Read more ...

Axsome Therapeutics (NASDAQ: AXSM ) +44%  as Avadel Pharmaceuticals gains  34%  on  positive data  on lead drug. More news on: Axsome Therapeutics, Inc., Avadel Pharmaceuticals plc, Yield10 Bioscience, Inc., Stocks on the move, , Read more ...

Are These Penny Stocks On Your List Today? The stock market today is seeing a mix of trading with several penny stocks benefiting. Taking over headlines once again, oil, COVID-19, and the economy are key drivers to both sell-offs and breakouts. But which one prevails by the end of the month?...

Mesoblast (NASDAQ: MESO ) +119%  as cell therapy shows significant benefit in COVID-19 patients. More news on: Mesoblast Limited, Medigus Ltd., Pluristem Therapeutics Inc., Stocks on the move, , Read more ...

Source: company website Biotech Vaxart ( VXRT ) jumped pre-market on April 21 on the news it had achieved positive results in pre-clinical trials concerning work on its oral vaccine candidates for COVID-19. In this article we'll examine the implications of the progress on the share p...